Fundraising

Adcytherix

Adcytherix Raises $122M in Series A

2024
Founded
40+
Employees
Paris, France
2 min read

Quick Facts

Adcytherix Raises $122M in Series A


Adcytherix has successfully raised $122M in a Series A at a $122M valuation led by Bpifrance, Kurma Partners, Andera Partners, Angelini Ventures.


Company Overview


Adcytherix is a Biotech company headquartered in Paris, France, founded in 2024 with 40+ employees.


Antibody-drug conjugate biotech for cancer therapeutics with novel linker technology


Fundraising Details


  • Amount Raised: $122M
  • Round Type: Series A
  • Valuation: $122M
  • Date: 2025-10-16
  • Investors: Bpifrance, Kurma Partners, Andera Partners, Angelini Ventures

About Adcytherix


Antibody-drug conjugate biotech for cancer therapeutics with novel linker technology The company is positioned in the Biotech sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: Paris, France
  • Founded: 2024
  • Team Size: 40+
  • Industry: Biotech

What This Means


This funding round demonstrates strong investor confidence in Adcytherix's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The Biotech sector continues to attract significant investment as companies innovate to meet evolving market demands. Adcytherix's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $122M valuation marks an important milestone for Adcytherix, positioning the company among notable players in the Biotech industry.


Looking Ahead


With this new capital, Adcytherix is well-positioned to execute on its growth strategy and continue building innovative solutions in the Biotech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2025-10-16. For more information about Adcytherix, visit their headquarters at Paris, France.

About the Author

Fundraising News Team
Fundraising News Team
Tracking the latest funding rounds and investment news